Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
出版年份 2020 全文链接
标题
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 20, Pages 4831
出版商
MDPI AG
发表日期
2020-10-21
DOI
10.3390/molecules25204831
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
- (2020) Dean C. Singleton et al. BMC CANCER
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer
- (2020) Xiaoguang Liu et al. NATURE CELL BIOLOGY
- Future Challenges in Cancer Resistance to Immunotherapy
- (2020) Marit J. van Elsas et al. Cancers
- Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
- (2020) Michael F. Coleman et al. Cancers
- A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
- (2020) Katharina Koch et al. Cell Death Discovery
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation
- (2019) Yuting Sun et al. Cell Reports
- Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
- (2019) Manpreet Sambi et al. Journal of Oncology
- Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
- (2019) Tengjiao Fan et al. Cancers
- Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2+/− Mice
- (2019) Ashley T. Jones et al. NEOPLASIA
- Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
- (2019) Yufeng Shi et al. NATURE
- CB-839, a glutaminase inhibitor, in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer (mRCC): Results of a phase I study.
- (2019) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Metabolism Drives a Stromal Regenerative Response
- (2019) Simon Schwörer et al. Cell Metabolism
- Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation
- (2019) Jinchul Kim et al. CANCER CELL
- Phase I trial of IACS-010759 (IACS), a potent, selective inhibitor of complex I of the mitochondrial electron transport chain, in patients (pts) with advanced solid tumors.
- (2019) Timothy A Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Stress responses in stromal cells and tumor homeostasis
- (2019) Ilio Vitale et al. PHARMACOLOGY & THERAPEUTICS
- Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
- (2019) Liang Zhang et al. Science Translational Medicine
- Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate
- (2019) Valentina Sica et al. Cell Reports
- The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells
- (2019) Li Wang et al. OncoTargets and Therapy
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Dendritic Cell Metabolism and Function in Tumors
- (2019) Paolo Giovanelli et al. TRENDS IN IMMUNOLOGY
- Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma
- (2019) Oscar Arrieta et al. JAMA Oncology
- Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
- (2019) Diane M. Demas et al. Frontiers in Oncology
- Multicentre, Open Label, Randomized Phase III Study of Cpi-613® (devimistat) in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (≥ 60 years) with Relapsed / Refractory Acute Myeloid Leukemia (AML) - Armada 2000 (AML003) Trial
- (2019) Timothy S. Pardee et al. BLOOD
- Mitochondrial Oxphos As Survival Mechanism of Minimal Residual AML Cells after Induction Chemotherapy : Survival Benefit By Complex I Inhibition with Iacs-010759
- (2019) Lina Han et al. BLOOD
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies
- (2019) Tom J. Harryvan et al. Journal of Clinical Medicine
- Targeting Glutamine Metabolism for Cancer Treatment
- (2018) Yeon-Kyung Choi et al. Biomolecules & Therapeutics
- Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells
- (2018) Saar Vandekeere et al. Cell Metabolism
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
- (2018) Azhar Ali et al. EMBO Molecular Medicine
- Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
- (2018) Fei Zhao et al. IMMUNITY
- The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model
- (2018) Efthymia Papaevangelou et al. INTERNATIONAL JOURNAL OF CANCER
- The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter
- (2018) Kuan-Hsun Wu et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
- (2018) Michaela Poliaková et al. Molecular Cancer
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer
- (2018) Yonathan Lissanu Deribe et al. NATURE MEDICINE
- A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
- (2018) Anthony Tolcher et al. ONCOLOGIST
- Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
- (2018) Dannielle DeWaal et al. Nature Communications
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells
- (2018) Hima V. Vangapandu et al. Oncotarget
- DNA Damage, Repair, and Cancer Metabolism
- (2018) Marc-Olivier Turgeon et al. Frontiers in Oncology
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression
- (2018) Christopher M. Rice et al. Nature Communications
- TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
- (2018) Ankur Chakravarthy et al. Nature Communications
- Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
- (2018) Don Benjamin et al. Cell Reports
- Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
- (2018) Jayshree Hirpara et al. Redox Biology
- Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
- (2018) Matilda Lee et al. Redox Biology
- Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
- (2017) Leisha A. Emens et al. EUROPEAN JOURNAL OF CANCER
- Fire and water: Tumor cell adaptation to metabolic conditions
- (2017) Rob A. Cairns et al. EXPERIMENTAL CELL RESEARCH
- Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics
- (2017) Aayushi Jain et al. Expert Review of Anticancer Therapy
- Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers
- (2017) Jennifer R. Diamond et al. INVESTIGATIONAL NEW DRUGS
- A phase Ib study of everolimus combined with metformin for patients with advanced cancer
- (2017) Remco J. Molenaar et al. INVESTIGATIONAL NEW DRUGS
- Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
- (2017) Angela Alistar et al. LANCET ONCOLOGY
- Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling
- (2017) Jianwei Liao et al. Molecular Cancer
- Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
- (2017) Elodie M Kuntz et al. NATURE MEDICINE
- Glutamine Addiction In Gliomas
- (2017) Javier Márquez et al. NEUROCHEMICAL RESEARCH
- Metabolic origins of spatial organization in the tumor microenvironment
- (2017) Carlos Carmona-Fontaine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stromal cues regulate the pancreatic cancer epigenome and metabolome
- (2017) Mara H. Sherman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
- (2017) Kenji Chamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
- (2017) Lindsay Wilde et al. SEMINARS IN ONCOLOGY
- Metformin synergizes with rapamycin to inhibit the growth of pancreatic cancer in�vitro and in�vivo
- (2017) Jia‑Wei Zhang et al. Oncology Letters
- Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer
- (2017) Zhou Song et al. Oncology Letters
- Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism
- (2017) Yong Liu et al. Oncotarget
- The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer
- (2017) Luo Lu et al. Oncotarget
- Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
- (2017) Medhi Wangpaichitr et al. Oncotarget
- Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel
- (2017) Hong Sun et al. Oncotarget
- Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
- (2017) Eva M. Palsson-McDermott et al. Frontiers in Immunology
- How Endothelial Cells Adapt Their Metabolism to Form Vessels in Tumors
- (2017) Annalisa Zecchin et al. Frontiers in Immunology
- Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism
- (2017) Balaraman Kalyanaraman Redox Biology
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment.
- (2017) Vanessa Costa Miranda et al. JOURNAL OF CLINICAL ONCOLOGY
- Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition
- (2017) Keisha N. Hardeman et al. Scientific Reports
- Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
- (2017) Xing Wang et al. Scientific Reports
- Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
- (2017) Maruša Bizjak et al. Scientific Reports
- Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
- (2017) Niki Marie Zacharias et al. Scientific Reports
- Vascular endothelial growth factor signaling requires glycine to promote angiogenesis
- (2017) Dongqing Guo et al. Scientific Reports
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
- (2016) C. Coyle et al. ANNALS OF ONCOLOGY
- Combined Treatment with 2-Deoxy-D-Glucose and Doxorubicin Enhances the in Vitro Efficiency of Breast Cancer Radiotherapy
- (2016) Jalil Pirayesh Islamian et al. Asian Pacific Journal of Cancer Prevention
- The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters
- (2016) B. Nancolas et al. BIOCHEMICAL JOURNAL
- Hallmarks of cancer stem cell metabolism
- (2016) Patricia Sancho et al. BRITISH JOURNAL OF CANCER
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- (2016) Raju V. Pusapati et al. CANCER CELL
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
- (2016) Muhammad R. Khawaja et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth
- (2016) Lifeng Yang et al. Cell Metabolism
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Emerging Opportunities and Challenges in Cancer Immunotherapy
- (2016) T. L. Whiteside et al. CLINICAL CANCER RESEARCH
- Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer
- (2016) Dongge Cai et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
- (2016) Cristovão M. Sousa et al. NATURE
- Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
- (2016) Emma M. Kerr et al. NATURE
- Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
- (2016) Evan C. Lien et al. NATURE CELL BIOLOGY
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin
- (2016) Eui Hyun Kim et al. NEURO-ONCOLOGY
- Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
- (2016) Barbara Marengo et al. Oxidative Medicine and Cellular Longevity
- Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
- (2016) M. Peng et al. SCIENCE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- CAF cellular glycolysis: linking cancer cells with the microenvironment
- (2016) Amrita Roy et al. TUMOR BIOLOGY
- Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma
- (2016) Matthew J. Martin et al. Oncotarget
- Altered glutamine metabolism in platinum resistant ovarian cancer
- (2016) Chantelle D. Hudson et al. Oncotarget
- PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
- (2016) Haiyan Zhu et al. Scientific Reports
- Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
- (2016) Laura Pisarsky et al. Cell Reports
- Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
- (2016) Geou-Yarh Liou et al. Cell Reports
- Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
- (2016) Hongyun Zhao et al. eLife
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
- (2015) A. L. Wong et al. ANNALS OF ONCOLOGY
- Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
- (2015) N. Jacque et al. BLOOD
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
- (2015) Patricia Sancho et al. Cell Metabolism
- Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
- (2015) I. L. Romero et al. CLINICAL CANCER RESEARCH
- Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) V. De Rosa et al. CLINICAL CANCER RESEARCH
- Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
- (2015) Mohamed Hassanein et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
- (2015) Lian Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
- (2015) Kazuhiro Tanaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- (2015) Yan Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
- (2015) Joe-Marc Chauvin et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
- (2015) Franziska Baenke et al. Molecular Oncology
- Fatty acid carbon is essential for dNTP synthesis in endothelial cells
- (2015) Sandra Schoors et al. NATURE
- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells
- (2015) Yunshan Wang et al. ONCOLOGY RESEARCH
- Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
- (2015) Dorota Klysz et al. Science Signaling
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
- (2015) Nikolaos Patsoukis et al. Nature Communications
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation
- (2015) Daoxiang Zhang et al. Cell Reports
- Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
- (2015) Dorota Klysz et al. Science Signaling
- PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
- (2015) Wei-Ren Liu et al. Oncotarget
- Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
- (2015) Anna Pastò et al. Oncotarget
- Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
- (2015) Benjamin Le Calvé et al. NEOPLASIA
- Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
- (2014) G Cheng et al. BRITISH JOURNAL OF CANCER
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1 and Oxidative Phosphorylation in Melanoma
- (2014) Y. N. V. Gopal et al. CANCER RESEARCH
- Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors
- (2014) Sameer H Issaq et al. CELL CYCLE
- Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
- (2014) Yao-An Shen et al. CELL CYCLE
- Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
- (2014) S. Dalva-Aydemir et al. CLINICAL CANCER RESEARCH
- Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing
- (2014) Oliver Coutelle et al. EMBO Molecular Medicine
- Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
- (2014) Mako Nakaya et al. IMMUNITY
- Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development
- (2014) David O’Sullivan et al. IMMUNITY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma
- (2014) Jonathan F. Bean et al. JOURNAL OF PEDIATRIC SURGERY
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
- (2014) Andrea Viale et al. NATURE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolism addiction in pancreatic cancer
- (2014) R Blum et al. Cell Death & Disease
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
- (2013) Krushna C. Patra et al. CANCER CELL
- LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
- (2013) David B. Shackelford et al. CANCER CELL
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Cancer metabolism, stemness and tumor recurrence
- (2013) Joseph M. Curry et al. CELL CYCLE
- Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
- (2013) R. Polanski et al. CLINICAL CANCER RESEARCH
- Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
- (2013) Amr Mohamed et al. Clinical Lung Cancer
- On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment
- (2013) Gerald Eibinger et al. EXPERIMENTAL CELL RESEARCH
- Therapeutic strategies impacting cancer cell glutamine metabolism
- (2013) Michael J Lukey et al. Future Medicinal Chemistry
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
- (2013) Stephen Yiu Chuen Choi et al. JOURNAL OF PATHOLOGY
- Glycolysis Inhibition Sensitizes Non-Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation
- (2013) S. M. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
- (2013) B. F. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Signal integration by mTORC1 coordinates nutrient input with biosynthetic output
- (2013) Christian C. Dibble et al. NATURE CELL BIOLOGY
- Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma
- (2013) P. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reverse Warburg Effect in a Patient With Aggressive B-Cell Lymphoma: Is Lactic Acidosis a Paraneoplastic Syndrome?
- (2013) Ubaldo E. Martinez-Outschoorn et al. SEMINARS IN ONCOLOGY
- Nutrient transporters: the Achilles’ heel of anabolism
- (2013) Alison N. McCracken et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Landscape of the mitochondrial Hsp90 metabolome in tumours
- (2013) Young Chan Chae et al. Nature Communications
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy
- (2012) S. K. McBrayer et al. BLOOD
- Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay
- (2012) T. Fiaschi et al. CANCER RESEARCH
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Using the “reverse Warburg effect” to identify high-risk breast cancer patients
- (2012) Agnieszka K. Witkiewicz et al. CELL CYCLE
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
- (2012) M. Hassanein et al. CLINICAL CANCER RESEARCH
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- mTOR, metabolism, and the regulation of T-cell differentiation and function
- (2012) Adam T. Waickman et al. IMMUNOLOGICAL REVIEWS
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
- (2012) Helge Frebel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
- (2012) Y. Liu et al. MOLECULAR CANCER THERAPEUTICS
- HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
- (2012) Ainara Elorza et al. MOLECULAR CELL
- Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response
- (2012) M. Beneteau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear Reprogramming with c-Myc Potentiates Glycolytic Capacity of Derived Induced Pluripotent Stem Cells
- (2012) Clifford D. L. Folmes et al. Journal of Cardiovascular Translational Research
- Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
- (2012) JIE ZHENG Oncology Letters
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- The role of amino acid transporters in inherited and acquired diseases
- (2011) Stefan Bröer et al. BIOCHEMICAL JOURNAL
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
- (2011) Marko Škrtić et al. CANCER CELL
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis
- (2011) F. Vegran et al. CANCER RESEARCH
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
- (2011) Jingtao Tong et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The kynurenine system and immunoregulation
- (2011) Yvette Mándi et al. JOURNAL OF NEURAL TRANSMISSION
- Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells
- (2011) Y. Zhuang et al. MOLECULAR CANCER RESEARCH
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
- (2011) Ayako Nakano et al. PLoS One
- Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
- (2011) D. A. Chan et al. Science Translational Medicine
- Oxidative phosphorylation in cancer cells
- (2010) Giancarlo Solaini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation
- (2010) C. M. Krawczyk et al. BLOOD
- Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
- (2010) Mahvash Zakikhani et al. BREAST CANCER RESEARCH AND TREATMENT
- Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
- (2010) Hua-shan Shi et al. CANCER SCIENCE
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
- (2010) J. D. Mezrich et al. JOURNAL OF IMMUNOLOGY
- Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation
- (2010) E. L. Carr et al. JOURNAL OF IMMUNOLOGY
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance
- (2009) Young-Kyoung Shin et al. ELECTROPHORESIS
- Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
- (2009) K. Dietl et al. JOURNAL OF IMMUNOLOGY
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
- (2009) Charles J. David et al. NATURE
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
- Function of Mitochondrial Stat3 in Cellular Respiration
- (2009) J. Wegrzyn et al. SCIENCE
- TGF-β and kynurenines as the key to infectious tolerance
- (2009) Maria L. Belladonna et al. TRENDS IN MOLECULAR MEDICINE
- l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms
- (2008) Kyoichi Kaira et al. CANCER SCIENCE
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- PD-1 Ligand Expression by Human Colonic Myofibroblasts/Fibroblasts Regulates CD4+ T-Cell Activity
- (2008) Irina V. Pinchuk et al. GASTROENTEROLOGY
- A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
- (2008) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
- (2008) Linda Strandberg Ihrlund et al. Molecular Oncology
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
- (2008) Vadivel Ganapathy et al. PHARMACOLOGY & THERAPEUTICS
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
- (2007) Elizabeth A. Johnson et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now